Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database

Infectious Disease in Obstetrics and Gynecology

Volumn 12, Issue 2, 2004, Pages 91-97

  Mårdh, Per Anders ^a   Wågström, Jolanta ^b   Landgren, Maria ^b   Holmén, Jan ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Apoteket AB   (Sweden)

^c Hospital Pharmacy   (Sweden)

Author keywords

Antifungal drugs; Over the Counter Products; Prescriptions; Recurrent Vulvovaginal Candidiasis; Vulvovaginal Candidiasis

Indexed keywords

ANTIFUNGAL AGENT; CLOTRIMAZOLE; ECONAZOLE; FLUCONAZOLE; ITRACONAZOLE; MICONAZOLE; NON PRESCRIPTION DRUG; PEVARYL DEPOT; PYRROLE DERIVATIVE;

ARTICLE; CANDIDA; COMMUNITY; COUNSELING; DATA BASE; DRUG INSTILLATION; DRUG MARKETING; PHARMACY; PRIORITY JOURNAL; PURCHASING; RECURRENT DISEASE; SELF MEDICATION; SWEDEN; VAGINA CANDIDIASIS;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; CLOTRIMAZOLE; DATABASES; DRUGS, NON-PRESCRIPTION; ECONAZOLE; FEMALE; HUMANS; MICONAZOLE; MIDDLE AGED; PHARMACIES; PRESCRIPTIONS, DRUG; RECURRENCE; SELF MEDICATION; SWEDEN;

EID: 10944273656     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1080/10647440400003873     Document Type: Article

References (18)

1. Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnosis and therapeutic considerations. Am J Obstet Gynecol 1998;178:203-11
2. Mårdh P-A, Rodrigues AG, Genç M, et al. Facts and myths on recurrent vulvovaginal candidosis - epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int J STD AIDS 2002;13:522-39
3. Ledger WJ. Current problems in the diagnosis and treatment of Candida vaginitis. Ital J Obstet Gynecol 1999;11:25-9
4. Novikova N, Mårdh P-A. Characterization of women with a history of recurrent vulvovaginal candidosis. Acta Obstet Gynecol Scand 2002;81:1047-52
5. Ferris DG, Dekle C, Litaker MS. Women's use of over-the-counter antifungal medications for gynecologic symptoms. J Fam Pract 1996;49:595-600
6. Sihro S, Ahonen R, Mikander H, Hemminki E. Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization. J Fam Pract 2000;17:145-9
7. Lynch ME, Sobel JD, Fidel PL. Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis. J Med Vet Mycol 1996;34:337-9
8. Sobel JD, Vasques JA. Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female not infected with human immunodefi-ciency virus. Clin Infect 1996;22:726-7
9. ACS, Apotekets Centrala Statistik [Database]. Apoteket AB, Sweden
10. Rodrigues A, Pina-Vaz C, Freitas da Fonseca A, et al. Progesterone influences germ tube formation and cell division of Candida species. Clin Microbiol Infect 2000;6(Suppl 1):96
11. Rodrigues A, Pina-Vaz C, Mårdh P-A, et al. In vitro effect of fibrinogen on Candida albicans germ tube formation. APMIS 1999;107:1020-2
12. Nwokolo NC, Boag FC. Chronic vaginal candidiasis. Management in the postmenopausal patient. Drugs Aging 2000;16:335-9
13. Mårdh P-A, Wågström J, Landgren M, Holmén J. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s. Infect Dis Obstet Gynecol 2004;12.
14. Odds FC. Resistance of yeasts to azole-derivative antifungals. J Antimicrob Chemother 1993;31:463-71
15. Frega A, Gallog D, Renzi F, et al. Persistent vulvovaginal candidiasis: systematic treatment with oral fluconazole. Clin Exp Obstet Gynecol 1994;21:259-62
16. Whittington Z, Cantrill J, Hassell K, et al. Community pharmacy management of minor conditions - the 'care of the chemist' scheme. Pharm J 2001;266:425-8
17. Sclar DA, Robison LM, Skaer TL. Pharmacy consultation and over-the-counter medication purchasing outcomes. Over-the-Counter Medication Intervention Project Team. J Clin Pharm Ther 1996;2:177-8
18. Garcia PJ, Gotuzzo E, Hughes JP, Holmes KK. Syndrome management of STDs in pharmacies: evaluation and randomized intervention trial. Sex Transm Infect 1998;74:153-8